These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9182838)

  • 1. Cell cycle perturbations in cisplatin-sensitive and resistant human ovarian carcinoma cells following treatment with cisplatin and low dose rate irradiation.
    Wilkins DE; Ng CE; Raaphorst GP
    Cancer Chemother Pharmacol; 1997; 40(2):159-66. PubMed ID: 9182838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased glutathione level is not involved in enhanced bleomycin sensitivity in cisplatin-resistant 2780CP cells.
    Tanaka T; Kurokawa H; Matsuno K; Matsumoto S; Hayashida Y
    Anticancer Res; 2008; 28(5A):2663-8. PubMed ID: 19035292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent pathways of p53 induction by cisplatin and X-rays in a cisplatin-resistant ovarian tumor cell line.
    Siddik ZH; Mims B; Lozano G; Thai G
    Cancer Res; 1998 Feb; 58(4):698-703. PubMed ID: 9485023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer chemo-endocrine therapy and its cell biological basis].
    Nishiya I
    Hum Cell; 1998 Sep; 11(3):109-14. PubMed ID: 10086273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T; Masuda H; Naito M; Tamai H
    Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells.
    Raaphorst GP; Miao J; Ng CE
    Anticancer Res; 1997; 17(5A):3469-72. PubMed ID: 9413189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
    Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of mifepristone on the proliferation, apoptosis, and cis-platinum (DDP) sensitivity of chemo-resistant human ovarian cancer cells].
    Wang G; Zheng WT; Xiao P; Li XJ; Lin TC; Li GY
    Ai Zheng; 2004 Apr; 23(4):406-11. PubMed ID: 15087028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of chronic thermotolerance by KNK437, a benzylidene lactam compound, enhances thermal radiosensitization in mild temperature hyperthermia combined with low dose-rate irradiation.
    Sakurai H; Kitamoto Y; Saitoh J; Nonaka T; Ishikawa H; Kiyohara H; Shioya M; Fukushima M; Akimoto T; Hasegawa M; Nakano T
    Int J Radiat Biol; 2005 Sep; 81(9):711-8. PubMed ID: 16368649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment.
    Raaphorst GP; Wang G; Stewart D; Ng CE
    Int J Radiat Biol; 1996 May; 69(5):623-31. PubMed ID: 8648250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of an S phase population of cells without DNA synthesis generated by cisplatin and pentoxifylline.
    Perras JP; Ramos R; Sevin BU
    Cytometry; 1993; 14(4):441-8. PubMed ID: 8513698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line.
    Siler DF; Wheeless CR; Dubin NH
    Cancer; 1996 May; 77(9):1850-3. PubMed ID: 8646684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells.
    Raaphorst GP; Miao J; Stewart D; Ng CE
    Cancer Chemother Pharmacol; 1998; 41(6):491-6. PubMed ID: 9554594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethality, DNA alkylation, and cell cycle effects of adozelesin (U-73975) on rodent and human cells.
    Bhuyan BK; Smith KS; Adams EG; Petzold GL; McGovren JP
    Cancer Res; 1992 Oct; 52(20):5687-92. PubMed ID: 1394193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug resistant mechanisms of platinum derivatives in a human cisplatin resistant ovarian cancer cell line].
    Nishiya I; Yoshizumi N; Fujiwara J; Kagabu T
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2871-81. PubMed ID: 3178236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
    Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity.
    Vaisman A; Varchenko M; Said I; Chaney SG
    Cytometry; 1997 Jan; 27(1):54-64. PubMed ID: 9000585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II).
    Masuda H; Tanaka T; Matsuda H; Kusaba I
    Cancer Res; 1990 Mar; 50(6):1863-6. PubMed ID: 2306738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.